Which imaging modalities are replacing nuclear scintigraphy for bone tumor evaluation, and why?

• A. Ultrasound
• B. CT or MRI
• C. Radiography
• D. PET-CT

Answer: (B)

CT or MRI are replacing nuclear scintigraphy for bone tumor evaluation because they provide superior anatomic detail and tissue characterization that improves accuracy for local staging and surgical planning. Nuclear scintigraphy is highly sensitive to areas of increased bone turnover but its specificity is limited; it can highlight a lesion without clearly showing its exact location, extent, or involvement of cortical bone and surrounding soft tissues, and it often can’t distinguish malignant from benign processes or healing changes.

Computed tomography offers exquisite high-resolution detail of bone, showing cortical destruction, periosteal reactions, matrix mineralization, and the precise three-dimensional extent of the lesion. Magnetic resonance imaging excels at assessing marrow involvement and soft-tissue extension, nerve or vascular encasement, and edema, which is crucial for planning surgery or radiation therapy. Together, CT and MRI give a more complete and actionable picture than a bone scan.

PET-CT can provide metabolic information and is useful in broader staging, but it’s not a universal replacement for scintigraphy in routine bone tumor evaluation and is less commonly used as the primary modality in many veterinary settings.